Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rebamipide dose-response in dry eye
NCT00475319Phase 2Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- May 2007
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rebamipide ophthalmic solution in dry eye syndrome (DED), sponsored by Otsuka Pharmaceutical Co., Ltd.. Started May 2007; status: completed.
02
Drugs
rebamipide ophthalmic solution
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT00475319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00475319.